Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes

Nature
|October 3, 1985
PubMed

Insights

Avian v-myc oncogene expression abrogated growth factor dependence in hematopoietic cells. This oncogene suppressed c-myc expression, impacting cell growth regulation and differentiation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Oncogenes play a role in cell transformation by influencing growth factor signaling pathways.
  • Platelet-derived growth factor (PDGF) induces c-myc and c-fos, genes associated with fibroblast competence.
  • c-myc induction is critical, as its regulated expression can reduce fibroblast dependence on PDGF.

Purpose of the Study:

  • To investigate the impact of oncogenes on hematopoietic and lymphoid cell differentiation, immortalization, and growth factor dependence.
  • To examine the effects of avian v-myc oncogene expression in hematopoietic/lymphoid cells.

Main Methods:

  • Utilized recombinant murine retroviruses to express the avian v-myc oncogene.
  • Studied the effects on interleukin-3 (IL-3)-dependent and interleukin-2 (IL-2)-dependent cell lines.

Main Results:

  • Recombinant avian v-myc expression abrogated the requirement for growth factors (IL-3 or IL-2) in dependent cell lines.
  • v-myc expression led to the suppression of endogenous c-myc expression in these cells.

Conclusions:

  • The avian v-myc oncogene can override the need for specific growth factors in hematopoietic/lymphoid cells.
  • v-myc's ability to suppress c-myc suggests a complex regulatory role in cell proliferation and differentiation.